MAGEC2 and neoplasm: Since cyclin E has been considered an essential regulator of cell cycle transition from G1 to S, the finding that MAGE-C2 inhibits cyclin E degradation prompted us to investigate the role of MAGE-C2 in G1 to S phase transition in tumor cells.